The debate about treating "low T" in older men will heat up

The debate about treating "low T" in older men will heat up...due to controversy over testosterone's cardiovascular risk.

A recent JAMA study has Health Canada and the FDA investigating a possible link between testosterone therapy and heart attacks and strokes.

Critics say the JAMA study is flawed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote